SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-022546
Filing Date
2021-11-09
Accepted
2021-11-09 16:12:30
Documents
78
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avtx-20210930.htm   iXBRL 10-Q 1666626
2 EX-3.1 ex31avalotherapeuticsamend.htm EX-3.1 37597
3 EX-10.1 ex-101cooperationagreement.htm EX-10.1 64277
4 EX-31.1 ex311avtx3q2021.htm EX-31.1 11658
5 EX-31.2 ex-312avtx3q2021.htm EX-31.2 11547
6 EX-32.1 ex-321avtx3q2021.htm EX-32.1 10102
12 avtx-20210930_g1.jpg GRAPHIC 169430
  Complete submission text file 0001628280-21-022546.txt   9145811

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20210930.xsd EX-101.SCH 65337
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avtx-20210930_cal.xml EX-101.CAL 80043
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avtx-20210930_def.xml EX-101.DEF 411908
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20210930_lab.xml EX-101.LAB 792659
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20210930_pre.xml EX-101.PRE 550839
13 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20210930_htm.xml XML 1364687
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 211392282
SIC: 2834 Pharmaceutical Preparations